tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Ardent Health price target raised to $18 from $16 at Guggenheim

Guggenheim raised the firm’s price target on Ardent Health (ARDT) to $18 from $16 and keeps a Buy rating on the shares after Ardent reported Q1 EBITDA slightly above consensus. Ardent shares remain “uniquely attractive” in the context of the current policy backdrop, the analyst tells investors.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1